» Articles » PMID: 34594892

Mild Breakthrough Infection in a Healthcare Professional Working in the Isolation Area of a Hospital Designated for Treating COVID-19 Patients - Shaanxi Province, China, March, 2021

Overview
Journal China CDC Wkly
Date 2021 Oct 1
PMID 34594892
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

What Is Already Known About This Topic?: Healthcare workers are at high risk of acquiring COVID-19 from occupational exposure to COVID-19 virus during their daily medical service work. Excellent infection prevention and control measures and adequate personal protective equipment (PPE) are essential to reduce the risk of hospital-acquired COVID-19.

What Is Added By This Report?: On March 17, 2021, a female healthcare professional who already received both doses of the COVID-19 vaccination and was working in the isolation area of a designated COVID-19 hospital was diagnosed with COVID-19 in Xi'an city. Her exposure likely occurred five days before illness onset when she obtained nasopharyngeal and oropharyngeal swabs from the two imported cases that were identified as belonging to the B.1.1.7 lineage, the variant first detected in the United Kingdom.

What Are The Implications For Public Health Practices?: Since the healthcare worker had been fully vaccinated and had mild symptomatology, it is considered a mild breakthrough infection. All vaccines are associated with breakthrough infections. In addition to rigorous adherence to infection prevention and control measures, use of adequate PPE, and using good clinical practices, the potential role of chronic upper respiratory infection in acquiring COVID-19 during medical procedures deserves further consideration.

Citing Articles

Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac).

Anshory M, Wahono C, Pratama M, Rahman P, Nugraha A, Sekarani A J Res Health Sci. 2022; 22(2):e00551.

PMID: 36511263 PMC: 9818040. DOI: 10.34172/jrhs.2022.86.


Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis.

Deng L, Li P, Zhang X, Jiang Q, Turner D, Zhou C Sci Rep. 2022; 12(1):20763.

PMID: 36456577 PMC: 9714387. DOI: 10.1038/s41598-022-24220-7.


Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.

Liu S, Kang M, Zhao N, Zhuang Y, Li S, Song T Med Rev (2021). 2022; 2(2):169-196.

PMID: 35862507 PMC: 9274757. DOI: 10.1515/mr-2021-0021.


Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?.

Kanakan A, Mehta P, Devi P, Saifi S, Swaminathan A, Maurya R Front Microbiol. 2022; 13:763169.

PMID: 35308382 PMC: 8927057. DOI: 10.3389/fmicb.2022.763169.


Higher Vaccination Rate Predicts Reduction in SARS-CoV-2 Transmission across the United States.

Au J medRxiv. 2021; .

PMID: 34816265 PMC: 8609904. DOI: 10.1101/2021.11.14.21266325.


References
1.
Yang J, Koh H, Moon S, Yoo I, Ha E, You S . Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study. J Allergy Clin Immunol. 2020; 146(4):790-798. PMC: 7428784. DOI: 10.1016/j.jaci.2020.08.008. View

2.
Gomez-Ochoa S, Franco O, Rojas L, Raguindin P, Roa-Diaz Z, Minder Wyssmann B . COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol. 2020; 190(1):161-175. PMC: 7499478. DOI: 10.1093/aje/kwaa191. View

3.
Rivett L, Sridhar S, Sparkes D, Routledge M, Jones N, Forrest S . Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. Elife. 2020; 9. PMC: 7314537. DOI: 10.7554/eLife.58728. View

4.
Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N . Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review. Int J Environ Res Public Health. 2020; 17(8). PMC: 7215977. DOI: 10.3390/ijerph17082690. View

5.
Kashte S, Gulbake A, El-Amin Iii S, Gupta A . COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021; 34(3):711-733. PMC: 7937046. DOI: 10.1007/s13577-021-00512-4. View